{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:21:30Z","timestamp":1792603290180,"version":"4.5.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Prescription drug use is prevalent during pregnancy, yet there is limited knowledge about maternal-fetal safety and efficacy of this drug use because pregnant individuals have historically been excluded from clinical trials. Underrepresentation has resulted in a lack of data available to estimate or predict fetal drug exposure. Approaches to study fetal drug pharmacology are limited and must be evaluated for feasibility and accuracy. Anatomic and physiological changes throughout pregnancy fluctuate based on gestational age and can affect drug pharmacokinetics (PK) for both mother and fetus. Drug concentrations have been studied throughout different stages of gestation and at or following delivery in tissue and fluid biospecimens. Sampling amniotic fluid, umbilical cord blood, placental tissue, meconium, umbilical cord tissue, and neonatal hair present surrogate options to quantify and characterize fetal drug exposure. These sampling methods can be applied to all therapeutics including small molecule drugs, large molecule drugs, conjugated nanoparticles, and chemical exposures. Alternative approaches to determine PK have been explored, including physiologically based PK modeling,<jats:italic>in vitro<\/jats:italic>methods, and traditional animal models. These alternative approaches along with convenience sampling of tissue or fluid biospecimens can address challenges in studying maternal-fetal pharmacology. In this narrative review, we 1) present an overview of the current understanding of maternal-fetal drug exposure; 2) discuss biospecimen-guided sampling design and methods for measuring fetal drug concentrations throughout gestation; and 3) propose methods for advancing pharmacology research in the maternal-fetal population.<\/jats:p>","DOI":"10.3389\/fphar.2023.1111601","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T06:02:38Z","timestamp":1679551358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure"],"prefix":"10.3389","volume":"14","author":[{"given":"Rachel E.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torri D.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn M.","family":"McKnite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Y.","family":"Enioutina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Job","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"840710","DOI":"10.3389\/fped.2022.840710","article-title":"Application of a physiologically based pharmacokinetic approach to predict theophylline pharmacokinetics using virtual non-pregnant, pregnant, fetal, breast-feeding, and neonatal populations","volume":"10","author":"Abduljalil","year":"","journal-title":"Front. Pediatr."},{"key":"B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40262-018-0685-y","article-title":"Fetal physiologically based pharmacokinetic models: Systems information on the growth and composition of fetal organs","volume":"58","author":"Abduljalil","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/dmd.121.000711","article-title":"Prediction of maternal and fetoplacental concentrations of cefazolin, cefuroxime, and amoxicillin during pregnancy using bottom-up physiologically based pharmacokinetic models","volume":"50","author":"Abduljalil","year":"","journal-title":"Drug Metab. Dispos."},{"key":"B4","article-title":"Maternal, fetal, and neonatal pharmacokinetics","volume":"68","author":"Allegaert","year":"2016","journal-title":"Oxf. Textb. Obstetric Anaesth."},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.74038","article-title":"Animal models of fetal medicine and obstetrics","volume-title":"Experimental animal models of human diseases-an effective therapeutic strategy","author":"Andersen","year":"2018"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1002\/jcph.2117","article-title":"Predicting human fetal drug exposure through maternal\u2010fetal PBPK modeling and in vitro or ex vivo studies","volume":"62","author":"Balhara","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"F98","DOI":"10.1136\/fn.88.2.f98","article-title":"Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse","volume":"88","author":"Bar-Oz","year":"2003","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"B8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.placenta.2006.11.009","article-title":"Amniotic fluid water dynamics","volume":"28","author":"Beall","year":"2007","journal-title":"Placenta"},{"key":"B9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/infdis\/135.6.925","article-title":"Maternal-fetal pharmacological activity of amikacin","volume":"135","author":"Bernard","year":"","journal-title":"J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/AAC.11.4.688","article-title":"Tobramycin: Maternal-fetal pharmacology","volume":"11","author":"Bernard","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","volume-title":"Maternal, fetal, and neonatal physiology: A clinical perspective","author":"Blackburn","year":"1992"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.earlhumdev.2017.09.012","article-title":"Smell and taste in the preterm infant","volume":"114","author":"Bloomfield","year":"2017","journal-title":"Early Hum. Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1700786","DOI":"10.1002\/adhm.201700786","article-title":"Placental drug transport-on-a-chip: A microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier","volume":"7","author":"Blundell","year":"2018","journal-title":"Adv. Healthc. Mater"},{"key":"B14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1139\/y01-080","article-title":"The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study","volume":"79","author":"Boskovic","year":"2001","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9378(89)90527-9","article-title":"Normal amniotic fluid volume changes throughout pregnancy","volume":"161","author":"Brace","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1258\/jrsm.2008.08k033","article-title":"Why animal studies are often poor predictors of human reactions to exposure","volume":"102","author":"Bracken","year":"2009","journal-title":"J. R. Soc. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40262-022-01127-0","article-title":"Prediction of maternal and fetal doravirine exposure by integrating physiologically based pharmacokinetic modeling and human placenta perfusion experiments","volume":"61","author":"Bukkems","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"B18","volume-title":"Population pharmacokinetics (draft guidance)","year":"2019"},{"key":"B19","volume-title":"Research on medicines and pregnancy","year":"2022"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1128\/AAC.48.11.4332-4336.2004","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women","volume":"48","author":"Chappuy","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ajog.2004.01.034","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus","volume":"191","author":"Chappuy","year":"","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.clinbiochem.2017.03.006","article-title":"Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure","volume":"50","author":"Colby","year":"2017","journal-title":"Clin. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/humrep\/17.10.2564","article-title":"Metabolizing enzyme localization and activities in the first trimester human placenta: The effect of maternal and gestational age, smoking and alcohol consumption","volume":"17","author":"Collier","year":"2002","journal-title":"Hum. Reprod."},{"key":"B25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/FTD.0b013e31828a6148","article-title":"Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection","volume":"35","author":"Concheiro","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"B26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jat\/34.8.498","article-title":"Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes","volume":"34","author":"Concheiro","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40262-017-0594-5","article-title":"A physiologically based pharmacokinetic model for pregnant women to predict the pharmacokinetics of drugs metabolized via several enzymatic pathways","volume":"57","author":"Dallmann","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","article-title":"Gestation-specific changes in the anatomy and physiology of healthy pregnant women: An extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1002\/jcph.1491","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"","journal-title":"J. Clin. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1381612825666190320135137","article-title":"Clinical pharmacokinetic studies in pregnant women and the relevance of pharmacometric tools","volume":"25","author":"Dallmann","year":"","journal-title":"Curr. Pharm. Des."},{"key":"B31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/uog.20113","article-title":"Role of late amniocentesis in the era of modern genomic technologies","volume":"53","author":"Daum","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00228-009-0645-4","article-title":"Distribution of fentanyl in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women","volume":"65","author":"De Barros Duarte","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1212\/01.wnl.0000133213.10244.fd","article-title":"Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy study","volume":"63","author":"De Haan","year":"2004","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40262-016-0457-5","article-title":"A physiologically-based pharmacokinetic model to predict human fetal exposure for a drug metabolized by several CYP450 pathways","volume":"56","author":"De Sousa Mendes","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0378-3782(85)90174-4","article-title":"The emergence of fetal behaviour. II. Quantitative aspects","volume":"12","author":"De Vries","year":"1985","journal-title":"Early Hum. Dev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2125.1989.tb03501.x","article-title":"The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin","volume":"28","author":"Dickinson","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0091270010365551","article-title":"Distribution of bupivacaine enantiomers and lidocaine and its metabolite in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women","volume":"51","author":"Duarte","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","article-title":"Development and evaluation of a generic physiologically based pharmacokinetic model for children","volume":"45","author":"Edginton","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"B40","first-page":"231","article-title":"Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking","volume":"19","author":"Eliopoulos","year":"1996","journal-title":"Clin. Investigative Medicine-Medecine Clinique Exp."},{"key":"B41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-m","article-title":"Insignificant transfer of glyburide occurs across the human placenta","volume":"165","author":"Elliott","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B42","volume-title":"Guideline on the exposure to medicinal products during pregnancy: Need for post-authorisation data","year":"2005"},{"key":"B43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ntt.2005.04.001","article-title":"Relative ability of biologic specimens and interviews to detect prenatal cocaine use","volume":"27","author":"Eyler","year":"2005","journal-title":"Neurotoxicol Teratol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.etap.2017.11.007","article-title":"Changes in first trimester fetal CYP1A1 and AHRR DNA methylation and mRNA expression in response to exposure to maternal cigarette smoking","volume":"57","author":"Fa","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"951616","DOI":"10.1155\/2011\/951616","article-title":"Drug testing for newborn exposure to illicit substances in pregnancy: Pitfalls and pearls","volume":"2011","author":"Farst","year":"2011","journal-title":"Int. J. Pediatr."},{"key":"B46","first-page":"512","article-title":"Pharmacokinetics of drugs in pregnancy","volume-title":"Seminars in perinatology","author":"Feghali","year":"2015"},{"key":"B47","doi-asserted-by":"publisher","first-page":"497.e1","DOI":"10.1016\/j.ajog.2016.05.016","article-title":"Bupropion therapy during pregnancy: The drug and its major metabolites in umbilical cord plasma and amniotic fluid","volume":"215","author":"Fokina","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B48","unstructured":"Food, and Drug AdministrationH. 2023"},{"key":"B49","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule","volume":"79","author":"Food, and Drug Administration","year":"2014","journal-title":"Fed. Regist."},{"key":"B50","unstructured":"Pregnant women: Scientific and ethical considerations for inclusion in clinical trials Food, and Drug AdministrationH. 2018"},{"key":"B51","volume-title":"International counterparts","year":"2022"},{"key":"B52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/FTD.0b013e318178e2a9","article-title":"Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium","volume":"30","author":"Franco","year":"2008","journal-title":"Ther. drug Monit."},{"key":"B53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cca.2005.10.028","article-title":"Drugs of abuse testing in meconium","volume":"366","author":"Gareri","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"B54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41540-020-00157-3","article-title":"Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy","volume":"6","author":"George","year":"2020","journal-title":"NPJ Syst. Biol. Appl."},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1515\/jpme.1990.18.6.479","volume-title":"Maternal kinetics of morphine during labour","author":"Gerdin","year":"1990"},{"key":"B56","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.envint.2020.106301","article-title":"Pregnancy-specific physiologically-based toxicokinetic models for bisphenol A and bisphenol S","volume":"147","author":"Gingrich","year":"2021","journal-title":"Environ. Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/jp.2014.241","article-title":"A comprehensive study of umbilical cord blood cell developmental changes and reference ranges by gestation, gender and mode of delivery","volume":"35","author":"Glasser","year":"2015","journal-title":"J. Perinatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1007\/s00204-021-03111-2","article-title":"Structure-based virtual screening of CYP1A1 inhibitors: Towards rapid tier-one assessment of potential developmental toxicants","volume":"95","author":"Goh","year":"2021","journal-title":"Archives Toxicol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00216-007-1228-9","article-title":"Bioanalytical procedures for monitoring in utero drug exposure","volume":"388","author":"Gray","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"698611","DOI":"10.3389\/fped.2021.698611","article-title":"Regulatory considerations for the mother, fetus and neonate in fetal pharmacology modeling","volume":"9","author":"Green","year":"2021","journal-title":"Front. Pediatr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bjaceaccp\/mku013","article-title":"Placental structure, function and drug transfer","volume":"15","author":"Griffiths","year":"2015","journal-title":"Continuing Educ. Anaesth. Crit. Care and Pain"},{"key":"B62","first-page":"011","article-title":"Animal models to study placental development and function throughout normal and dysfunctional human pregnancy","volume-title":"Seminars in reproductive medicine","author":"Grigsby","year":"2016"},{"key":"B63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","article-title":"Prescription and other medication use in pregnancy","volume":"131","author":"Haas","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0006-2952(96)00216-x","article-title":"Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy","volume":"52","author":"Hakkola","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.placenta.2018.03.005","article-title":"Investigating human placentation and pregnancy using first trimester chorionic villi","volume":"65","author":"Hannibal","year":"2018","journal-title":"Placenta"},{"key":"B67","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P\u2010glycoprotein activities as measured by disposition of midazolam and digoxin: A university of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2008.02.005","article-title":"The ontogeny of drug metabolism enzymes and implications for adverse drug events","volume":"118","author":"Hines","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/1523-1747.ep12556818","article-title":"Structure of the human fetal hair canal and initial hair eruption","volume":"71","author":"Holbrook","year":"1978","journal-title":"J. Investig. Dermatol"},{"key":"B71","volume-title":"Integrated addedum to ICH E6(R1): Guideline for good clinical practice","year":"2016"},{"key":"B72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"Iqbal","year":"2012","journal-title":"Placenta"},{"key":"B73","article-title":"Amniocentesis","author":"Jindal","year":"2020","journal-title":"StatPearls"},{"key":"B74","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1203\/00006450-197502000-00009","article-title":"Placental transfer and fetal urinary excretion of gentamicin during constant rate maternal infusion","volume":"9","author":"Kauffman","year":"1975","journal-title":"Pediatr. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10928-020-09677-1","article-title":"Anatomical and physiological alterations of pregnancy","volume":"47","author":"Kazma","year":"2020","journal-title":"J. Pharmacokinet. pharmacodynamics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-pharmtox-011613-140009","article-title":"Pharmacometrics in pregnancy: An unmet need","volume":"54","author":"Ke","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1191\/096032799678840048","article-title":"Hair analysis-a biological marker for passive smoking in pregnancy and childhood","volume":"18","author":"Klein","year":"1999","journal-title":"Hum. Exp. Toxicol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0300-1652.107549","article-title":"Hormones in pregnancy","volume":"53","author":"Kumar","year":"2012","journal-title":"Niger. Med. J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1432-1033.1997.00625.x","article-title":"Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth","volume":"247","author":"Lacroix","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jcph.1515","article-title":"Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir","volume":"60","author":"Liu","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: A cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ open"},{"key":"B83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1067\/mob.2001.108344","article-title":"Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women","volume":"184","author":"Mandelbrot","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/FTD.0b013e3182a0d18c","article-title":"Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry","volume":"36","author":"Marin","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"B85","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/archpedi.1991.02160060068022","article-title":"Meconium for drug testing","volume":"145","author":"Maynard","year":"1991","journal-title":"Am. J. Dis. Child."},{"key":"B86","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00228-003-0651-x","article-title":"Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil","volume":"59","author":"Mcgready","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40262-020-00861-7","article-title":"Integration of placental transfer in a fetal-maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus","volume":"59","author":"Mian","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.jp.7211416","article-title":"Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium","volume":"26","author":"Montgomery","year":"2006","journal-title":"J. Perinatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/jp.2008.97","article-title":"Using umbilical cord tissue to detect fetal exposure to illicit drugs: A multicentered study in Utah and New Jersey","volume":"28","author":"Montgomery","year":"2008","journal-title":"J. Perinatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1517\/17425250903304049","article-title":"Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues","volume":"5","author":"Myllynen","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tiv.2012.08.027","article-title":"Placental transfer and metabolism: An overview of the experimental models utilizing human placental tissue","volume":"27","author":"Myllynen","year":"2013","journal-title":"Toxicol Vitro"},{"key":"B92","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.tiv.2010.12.010","article-title":"A high content screening assay for identifying lysosomotropic compounds","volume":"25","author":"Nadanaciva","year":"2011","journal-title":"Toxicol Vitro"},{"key":"B93","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1248\/yakushi.123.369","article-title":"Tissue distribution of mrna expression of human cytochrome P450 isoforms assessedby high-sensitivity real-time reverse transcription PCR","volume":"123","author":"Nishimura","year":"2003","journal-title":"Yakugaku zasshi"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e0152740","DOI":"10.1371\/journal.pone.0152740","article-title":"Metabolomics of human amniotic fluid and maternal plasma during normal pregnancy","volume":"11","author":"Orczyk-Pawilowicz","year":"2016","journal-title":"PLoS One"},{"key":"B95","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-3476(89)80860-1","article-title":"Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing","volume":"115","author":"Ostrea","year":"1989","journal-title":"J. Pediatr."},{"key":"B96","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1067\/mpd.2001.111429","article-title":"Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis","volume":"138","author":"Ostrea","year":"2001","journal-title":"J. Pediatr."},{"key":"B97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.schres.2017.09.043","article-title":"Pregnancy exposure to quetiapine - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomes","volume":"195","author":"Paulzen","year":"2018","journal-title":"Schizophrenia Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"","journal-title":"J. Affect. Disord."},{"key":"B99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pnpbp.2017.06.030","article-title":"Pregnancy exposure to citalopram - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"79","author":"Paulzen","year":"","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B100","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jad.2020.02.010","article-title":"Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomes","volume":"266","author":"Paulzen","year":"2020","journal-title":"J. Affect Disord."},{"key":"B101","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/138920009788897993","article-title":"Variation of drug kinetics in pregnancy","volume":"10","author":"Pavek","year":"","journal-title":"Curr. drug Metab."},{"key":"B102","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/138920009788897993","article-title":"Variation of drug kinetics in pregnancy","volume":"10","author":"Pavek","year":"","journal-title":"Curr. Drug Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1800112","DOI":"10.1002\/gch2.201800112","article-title":"Placenta-on-a-Chip: In vitro study of caffeine transport across placental barrier using liquid chromatography mass spectrometry","volume":"3","author":"Pemathilaka","year":"2019","journal-title":"Glob. Chall."},{"key":"B104","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1124\/dmd.121.000733","article-title":"Estimation of fetal-to-maternal unbound steady-state plasma concentration ratio of P-glycoprotein and\/or breast cancer resistance protein substrate drugs using a maternal-fetal physiologically based pharmacokinetic model","volume":"50","author":"Peng","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"B105","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0028-2243(91)90122-2","article-title":"Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound","volume":"40","author":"Pons","year":"1991","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.tiv.2009.07.028","article-title":"Modeling placental transport: Correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion","volume":"23","author":"Poulsen","year":"2009","journal-title":"Toxicol Vitro"},{"key":"B107","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000046537","article-title":"Hematologic and immunophenotypic characterization of human umbilical cord blood","volume":"105","author":"Pranke","year":"2001","journal-title":"Acta Haematol."},{"key":"B108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/j.1875-9114.1992.tb04505.x","article-title":"Oral nifedipine pharmacokinetics in pregnancy\u2010induced hypertension","volume":"12","author":"Prevost","year":"1992","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.placenta.2019.12.001","article-title":"Umbilical cord as an analytical matrix - a technical note","volume":"90","author":"Price","year":"2020","journal-title":"Placenta"},{"key":"B110","first-page":"606","article-title":"Fetal swallowing and amniotic fluid volume","volume":"28","author":"Pritchard","year":"1966","journal-title":"Obstet. Gynecol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1124\/dmd.110.033571","article-title":"The role of the placenta in fetal exposure to xenobiotics: Importance of membrane transporters and human models for transfer studies","volume":"38","author":"Prouillac","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B112","volume-title":"Amniocentesis","author":"Pruthi","year":"2020"},{"key":"B113","doi-asserted-by":"publisher","first-page":"105471","DOI":"10.1016\/j.tiv.2022.105471","article-title":"Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling","volume":"85","author":"Roelofsen","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"B114","volume-title":"The umbilical cord","author":"Sch\u00f6ni-Affolter","year":"2007"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/bcp.15018","article-title":"Physiologically based pharmacokinetic modelling in pregnancy: Model reproducibility and external validation","volume":"88","author":"Silva","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/humrep\/15.11.2423","article-title":"A study on placental transfer of diclofenac in first trimester of human pregnancy","volume":"15","author":"Siu","year":"2000","journal-title":"Hum. Reprod."},{"key":"B117","article-title":"Meconium","volume-title":"StatPearls","author":"Skelly","year":"2020"},{"key":"B118","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/jat\/22.6.406","article-title":"The incorporation of drugs into hair: Relationship of hair color and melanin concentration to phencyclidine incorporation","volume":"22","author":"Slawson","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajog.2013.07.014","article-title":"Fetal blood sampling","volume":"209","author":"Society for Maternal-Fetal","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/j.2205-0140.2012.tb00013.x","article-title":"The development, structure and blood flow within the umbilical cord with particular reference to the venous system","volume":"15","author":"Spurway","year":"2012","journal-title":"Australas. J. Ultrasound Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/diagnostics11061098","article-title":"Difference in procedure-related risk of miscarriage between early and mid-trimester amniocentesis: A retrospective cohort study","volume":"11","author":"Steinfort","year":"2021","journal-title":"Diagnostics"},{"key":"B122","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"B123","first-page":"59","article-title":"Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy","volume":"52","author":"Szeto","year":"1978","journal-title":"Obstet. Gynecol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1528-1157.1994.tb02922.x","article-title":"Disposition of carbamazepine and phenytoin in pregnancy","volume":"35","author":"Tomson","year":"1994","journal-title":"Epilepsia"},{"key":"B125","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1515\/jpme.1982.10.2.119","article-title":"Ritodrine concentrations in maternal and fetal serum and amniotic fluid","volume":"10","author":"Van Lierde","year":"1982","journal-title":"J. Perinat. Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.medj.2021.04.010","article-title":"Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the US FDA","volume":"2","author":"Vasisht","year":"2021","journal-title":"Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4323\/rjlm.2017.185","article-title":"Detection of drugs in paired maternal and umbilical cord blood samples","volume":"25","author":"Veit","year":"2017","journal-title":"Romanian J. Leg. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00003088-199528050-00001","article-title":"Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations","volume":"28","author":"Ward","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"B129","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.clp.2019.02.014","article-title":"Principles of pharmacokinetics in the pregnant woman and fetus","volume":"46","author":"Ward","year":"2019","journal-title":"Clin. Perinatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/h05-003","article-title":"Physiological adaptation in early human pregnancy: Adaptation to balance maternal-fetal demands","volume":"31","author":"Weissgerber","year":"2006","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajog.2021.02.032","article-title":"Prescription medications for use in pregnancy-perspective from the US Food and drug administration","volume":"225","author":"Wesley","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/pd.1970151307","article-title":"Early amniocentesis: A clinical review","volume":"15","author":"Wilson","year":"1995","journal-title":"Prenat. Diagn"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/bcp.13642","article-title":"Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/dmd.117.075192","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model I: Insights into factors that determine fetal drug exposure through simulations and sensitivity analyses","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"B135","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/clpt.2010.298","article-title":"Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review","volume":"89","author":"Zhao","year":"2011","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1111601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T12:53:33Z","timestamp":1702126413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1111601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":135,"alternative-id":["10.3389\/fphar.2023.1111601"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1111601","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"article-number":"1111601"}}